Source: Health Canada shortage reports · Updated Jul 24, 2026
Some Dapagliflozin products are in shortage in Canada (4 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An SGLT2 inhibitor used to lower blood sugar in type 2 diabetes and to treat heart failure.
Products affected
4 / 11
In shortage since
Dec 9, 2025
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · since Jun 9, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DAPAGLIFLOZIN
5MG · TABLET · APOTEX INC
DIN 02527189 · since Jan 27, 2026, est. end May 15, 2026 · Disruption of the manufacture of the drug.
Active shortage
GLN-DAPAGLIFLOZIN
10MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519860 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
GLN-DAPAGLIFLOZIN
5MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519852 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended May 22, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP DAPAGLIFLOZIN
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02531372 · ended Apr 7, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended Nov 27, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DAPAGLIFLOZIN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02518740 · ended May 26, 2025 · Delay in shipping of the drug.
Resolved
PMS-DAPAGLIFLOZIN
5MG · TABLET · PHARMASCIENCE INC
DIN 02531550 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-DAPAGLIFLOZIN
5MG · TABLET · AURO PHARMA INC
DIN 02531402 · ended Jan 31, 2025 · Demand increase for the drug.
Resolved
AURO-DAPAGLIFLOZIN
10MG · TABLET · AURO PHARMA INC
DIN 02531410 · ended Jan 28, 2025 · Demand increase for the drug.
Resolved
SANDOZ DAPAGLIFLOZIN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02518740 · ended Aug 12, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Dapagliflozin is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, GLENMARK PHARMACEUTICALS CANADA INC..
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Dapagliflozin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BK).
Recent changes
No changes recorded yet.
Common questions
What is Dapagliflozin used for?
An SGLT2 inhibitor used to lower blood sugar in type 2 diabetes and to treat heart failure.
When will Dapagliflozin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Dapagliflozin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.